Survey - Allergic Rhinitis with Exercise-Induced Bronchospasm-MontinaL-26-27MCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max Size - 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size - 2 MB)Choose File Clinical Insight Mapping: “Allergic Rhinitis with Exercise-Induced Bronchospasm: Real-World HCP Insights, Clinical Perspectives & Evolving Management Strategies”1. How frequently do your Allergic Rhinitis (AR) patients report exercise-related respiratory symptoms? Very frequently (More than 75% patients) Frequently (50–75%) Occasionally (25–50%) Rarely (Less than 25%)2. Do you routinely evaluate AR patients for Exercise-Induced Bronchospasm (EIB)? Always Often Sometimes Never3. Which symptom most commonly raises suspicion of EIB in AR patients? Cough Wheeze Breathlessness Chest tightness4. How do you view the relationship between AR and EIB? Part of a unified airway disease Frequently co-existing conditions Occasionally related Completely independent5. What is your initial management approach in AR patients with exercise-related symptoms? Treat AR alone Add bronchodilator (SABA) as needed Combination approach (AR + bronchial control) Observe before escalation6. Which strategy do you prioritize to improve exercise tolerance? Optimize AR control Pre-exercise bronchodilator use Combination of both Lifestyle/non-pharmacological measures7. What is your experience with Montelukast + Levocetirizine in AR patients with exercise-related symptoms? Highly effective Moderately effective Limited benefit Not preferred8. Compared to antihistamine monotherapy, this combination provides: Better overall control (AR + EIB) Better control only in selected patients Similar effect No added benefit9. What is the biggest challenge in managing AR patients with EIB? Incomplete symptom control Delayed or missed diagnosis Patient non-compliance Multiple overlapping triggers10. What prompts you to escalate therapy in AR with EIB? Persistent symptoms despite treatment Reduced exercise tolerance Increased reliance on rescue inhaler (SABA) Patient expectation/quality of life impact11. Which non-pharmacological strategy do you commonly recommend? Warm-up before exercise Allergen avoidance Breathing techniques Rarely recommend non-pharmacological measures12. What defines successful management in AR with EIB? Improved exercise tolerance Reduced need for rescue inhaler Symptom-free physical activity Overall quality of life improvement I have read and agree to the Terms and Conditions .Submit Form